PBRM1 and renal cell carcinoma: Likewise, the rate of abrogating mutations in PBRM1 is (21.1%) [22.5%] out of a total mutation rate of (26.6%) [27.5%] in renal cell carcinomas as indicated in the TCGA and Cosmic databases (Table 4A).